Jeffrey David Jonker

Insider Reports History

Entity
Individual
Location
C/O Ngm Biopharmaceuticals, Inc., 333 Oyster Point Blvd., South San Francisco, CA
Signature
/s/ Michael York, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey David Jonker:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Metacrine, Inc. Director Stock Option (right to buy) 16.5K May 18, 2022 Direct

Insider Reports Filed by Jeffrey David Jonker

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MTCR Metacrine, Inc. May 18, 2022 1 $0 4 Sep 6, 2022 Director
MTCR Metacrine, Inc. May 24, 2021 1 $0 4 May 25, 2021 Director